FAQ
open menu
About Us
About Us
Management Team
Our Companies
Nebula Genomics
ProPhase Diagnostics
ProPhase Biopharma
Pharmaloz Manufacturing
TK Supplements
Investor Relations
Presentations
News & Events
Press Releases
Media Mentions
IR Calendar
Email Alerts
Company Info
Management Team
Contacts
FAQ
Financial Info
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Board Committees
Governance Documents
Contact Us
Corporate
Diagnostics
Pharmaloz
TKSupplements
Media Mentions
Investors
Investors
Overview
Presentations
News & Events
Press Releases
Media Mentions
IR Calendar
Email Alerts
Company Info
Management Team
Contacts
FAQ
Financial Info
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Board Committees
Governance Documents
Jan 13, 2021
ProPhase targets 'enormous goal,' expects $100M in new revenue from Covid-19 pivot
rss_feed
RSS
arrow_back
1
2
Email Alerts
Contacts
RSS News Feed
